Overview

Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.
Phase:
Phase 2
Details
Lead Sponsor:
Netherlands Institute for Pigment Disorders
Treatments:
Triamcinolone Acetonide